Effects of a protease inhibitor, ulinastatin, on coagulation and fibrinolysis in abdominal surgery

[1]  E. Plow.  The contribution of leukocyte proteases to fibrinolysis , 1986, Blut.

[2]  K. Hanaoka,et al.  Do the effects of a protease inhibitor, ulinastatin, on elastase release by blood transfusion depend on interleukin 6? , 2001, Critical care medicine.

[3]  H. Tsujimoto,et al.  Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. , 2001, Shock.

[4]  Y. Yamaguchi,et al.  Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion. , 2000, The Journal of surgical research.

[5]  Y. Hasegawa,et al.  Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin. Inhibiting cytokines and postoperative organ injury. , 2000, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[6]  T. Itoh,et al.  Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. , 2000, The Annals of thoracic surgery.

[7]  M. Aibiki,et al.  The Effect of Ulinastatin, a Human Protease Inhibitor, on the Transfusion-Induced Increase of Plasma Polymorphonuclear Granulocyte Elastase , 1996, Anesthesia and analgesia.

[8]  S. Gando,et al.  Cytokines, soluble thrombomodulin and disseminated intravascular coagulation in patients with systemic inflammatory response syndrome. , 1995, Thrombosis research.

[9]  R. Wakusawa,et al.  [The inhibitory effects of ulinastatin on the increase of interleukin 8 and 6 during open heart surgery]. , 1994, Masui. The Japanese journal of anesthesiology.

[10]  J. Bienvenu,et al.  Coagulation/fibrinolysis balance in septic shock related to cytokines and clinical state. , 1994, Haemostasis.

[11]  M. Morad,et al.  Caffeine-induced Ca2+ release activates Ca2+ extrusion via Na+-Ca2+ exchanger in cardiac myocytes. , 1989, The American journal of physiology.

[12]  J. Pierce,et al.  The α1-antitrypsin gene and emphysema , 1989 .

[13]  R. Senior,et al.  The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant , 1988, The Journal of experimental medicine.

[14]  K. Ohlsson,et al.  Influence of plasma protease inhibitors and the secretory leucocyte protease inhibitor on leucocyte elastase-induced consumption of selected plasma proteins in vitro in man. , 1988, Scandinavian journal of clinical and laboratory investigation.

[15]  H. Pelzer,et al.  Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.

[16]  T. Yoshikawa,et al.  [Prevention of endotoxin-induced disseminated intravascular coagulation, and inhibition of endotoxin-induced release of thromboplastin activity from leukocytes by a protease-inhibitor, urinastatin]. , 1987, Masui. The Japanese journal of anesthesiology.

[17]  J. Fenton,et al.  Human neutrophil elastase alters human alpha-thrombin function: limited proteolysis near the gamma-cleavage site results in decreased fibrinogen clotting and platelet-stimulatory activity. , 1987, Blood.

[18]  M. Taki,et al.  Influence of granulocyte elastase-like proteinase (ELP) on platelet functions. , 1986, Thrombosis research.

[19]  M. Jochum,et al.  Effect of human granulocytic elastase on isolated human antithrombin III. , 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[20]  S. Lopaciuk,et al.  Effects of Neutral Proteases from Human Leukocytes on Structure and Biological Properties of Human Factor VIII , 1980, Thrombosis and Haemostasis.

[21]  K. Ohlsson,et al.  Granulocyte elastase activation and degradation of factor XIII. , 1980, Thrombosis research.